{{expand english|time=2018-09-29T00:40:11+00:00}}
{{Expand|time=2011-09-16T07:39:48+00:00 }}
{{medical}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 407971997
| IUPAC_name = (''Z'')-5-[(4''R'',5''R'')-5-hydroxy-4-((''S,E'')-3-hydroxyoct-1-enyl)hexahydro-2''H''-cyclopenta[''b'']furan-2-ylidene]pentanoic acid
| image = Prostacyclin-2D-skeletal.png
| width = 200px
| image2 = Prostacyclin spacefill.png

<!--Clinical data-->
| tradename =  
| Drugs.com = {{drugs.com|monograph|iloprost}}
| pregnancy_category =  
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|CAS}}
| CAS_number = 35121-78-9
| ATC_prefix = B01
| ATC_suffix = AC09
| ATC_supplemental =  
| PubChem = 114805
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = APRD00949
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 962

<!--Chemical data-->
| C=20 | H=32 | O=5 
| molecular_weight = 352.465 g/mol
| smiles = OC(=O)CCC\C=C1\C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]2O1
}}
'''前列环素<ref>[http://www.term.gov.cn/pages/homepage/result2.jsp?id=334433&subid=10001798&subject=%E6%BF%80%E7%B4%A0%E4%B8%8E%E7%BB%B4%E7%94%9F%E7%B4%A0&subsys=%E7%94%9F%E7%89%A9%E5%8C%96%E5%AD%A6%E4%B8%8E%E5%88%86%E5%AD%90%E7%94%9F%E7%89%A9%E5%AD%A6]{{dead link|date=2017年11月 |bot=InternetArchiveBot |fix-attempted=yes }}</ref>'''（{{lang-en|Prostacyclin}}，简称为'''PGI<sub>2</sub>'''）是[[脂类|脂类]]中[[类花生酸|类花生酸]]家族中的一个成员，分子中有一个次级五元环，其前体是[[花生四烯酸|花生四烯酸]]或其他二十碳不饱和脂肪酸。前列环素会抑制[[血小板|血小板]]介导的凝集过程并有强烈的血管舒张作用，因此在[[凝血|凝血作用]]中，受损血管内皮的前列环素生成量会减少，这有利于血小板的聚集。

==参考文献==
{{reflist}}
{{Antithrombotics}}
{{PAH rx}}
{{Prostaglandins}}
{{类花生酸}}

[[Category:前列腺素类|Category:前列腺素类]]
[[Category:吉利德科学|Category:吉利德科学]]
[[Category:醇|Category:醇]]
[[Category:羧酸|Category:羧酸]]